Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International
GAITHERSBURG, Md., March 19, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has completed the sale of its Baltimore-Bayview drug substance manufacturing ...
Fierce Pharma15d
Indian contractor Syngene throws down $37M for Emergent's Baltimore biologics plant
As Emergent BioSolutions continues to pawn off manufacturing real estate in its pivot from production specialist to full-time drug developer, Indian CRDMO Syngene International is capitalizing on t | ...
2 MD Hospitals Among Best In The World, New Ranking Says
Seven hospitals in Maryland are among the best in the U.S, with two ranked among the best 250 in the world, according to a ...
Business Insider15d
Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International
GAITHERSBURG, Md., March 10, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has entered into an agreement to sell its Baltimore-Bayview drug substance ...